Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 34K - 34K
Notice Type:
Contract award notice
Published Date:
26 February 2021
Closing Date:
Location(s):
FR FRANCE
Description:
AO 20RC2 — remise en concurrence Médicaments — Pharmsera

AO 20RC2 — remise en concurrence Médicaments — Pharmsera.


Ambrisentan forme orale sèche

AO 20RC2 — remise en concurrence médicaments — Pharmsera.

Awarded to:
Ambrisentan forme orale sèche
Mylan, Saint-Priest Cedex (FR)
Download full details as .pdf
The Buyer:
CH Annecy Genevois
CPV Code(s):
33600000 - Pharmaceutical products